Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 88
    Published on November 29, 2016


About End Stage Renal Disease (ESRD)

A study done by researchers from Oslo University Hospital, Norway shows individuals with type 1 diabetes (T1D) developed between 15 and 27 years have low cumulative incidence of end-stage renal disease (ESRD). Researchers found following in their 30 years of follow-up study


  • Low incidence of end-stage renal disease (ESRD) - 4.6 percent
  • Mortality increased during the long-term follow-up - 20.6 percent
  • Death due to alcohol consumption was recorded at 15 percent
  • Death due to chronic complications recorded 32.2 percent
  • Death due to acute complications recorded 20.5 percent
  • Violet death recorded 19.9 percent
  • Death due to other causes was recorded at 27.4 percent

The study involved 719 patients with type 1 diabetes (T1D) and the study was done by Vibeke Gagnum and the study findings were published in Diabetes Care.




       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Renal Denervation To Improve Insulin Sensitivity
2. Study Of Estimated Glomerular Filtration Rate (eGFR) On End Stage Renal Disease (ESRD) Patients
3. Access Crosby Wearable Fitness Tracking Products From Michael Kors
4. Activity Trackers And Wearable Devices From Alcatel
5. Portable Device To Check Diabetes With Exhale Of Acetone Chemical

 

ESRD : End Stage Renal Disease (ESRD) is related to the kidney. The disease will be diagnosed with physical examination and analysis of urine (with urinalysis test) for protein and blood. The average lifespan for ESRD patients is

  • ESRD patients may lose their life within 4 weeks if they stop dialysis
  • Lifespan is 4.25 years on average in those ESRD patients who started dialysis
  • 23 percent of the ESRD patients who started dialysis may live up to 10 years

Individual may prevent ESRD by

  • Not smoking
  • Not drinking alcohol
  • Reducing body mass index (BMI)
  • Eating healthy diet
  • Reducing salt consumption
  • Not leading sedentary behavior

 

Insulin Delivery & Blood Sugar Levels Measuring Closed Loop (IDCL) Trial By Tandem Diabetes Care, Dexcom and TypeZero Technologies

A good automatic insulin delivery system should be simple to use, supported with accurate CGM data and calculations based on algorithms giving proper and useful feedback. Tandem Diabetes Care, Dexcom and TypeZero Technologies are working together by integrating their technologies for Diabetes Closed Loop (IDCL) trial. This trial is NIH funded and going to start during later part of this year. The closed-loop control-to-range system integrates following products


  • Insulin pump to inject insulin into the body from Tandem Diabetes Care, Inc
  • Sensor from Dexcom, Inc to measure glucose levels
  • inControl closed-loop algorithm from TypeZero Technologies, Inc

The product can estimate blood sugar levels continuously and can deliver basal insulin accordingly. The product allows the user to manually bolus for meals and automates correction boluses. 240 adults with type 1 diabetes patients (T1D) are expected to take part in IDCL trial. The principal investigator of the IDCL trial is Dr. Boris Kovatchev, PhD, Director of the Center for Diabetes Technology at the University of Virginia.




       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Insulin Related Cancer Risk Offset Benefits With Statins Usage
2. Low Carbohydrate Diet Lowers Insulin Resistance
3. Better Way To Manage Blood Sugar Levels With Diabetes Apps
4. Risks With High Sugar Levels
5. About Tandem Diabetes Care, Inc

 

 

High Levels Of Iron in Pregnant Women Is A Risk To Gestational Diabetes

A study done by researchers shows high levels of iron in women during second (also first) trimester of pregnancy doubles risk to gestational diabetes (GD). Women can protect themselves from gestational diabetes (GD) by optimizing her weight before she decides to become pregnant. The study just shows an association between iron levels and gestational diabetes. This study shows every pregnant woman should not be treated with iron supplements. Author of the study is Shristi Rawal and the study findings were published in the journal Diabetologia.




       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Benefits With Exercise For Obese Pregnant Women
2. Risks With Type 1 Diabetes (T1D) In Pregnant Women Carrying Twins
3. Study Of Gestational Diabetes (GD)
4. Risks With Gestational Diabetes (GD)
5. Gestational Diabetes Risk During Summer

 

Iron : Hemoglobin protein in red blood cells require iron mineral. Iron in hemoglobin carries oxygen to cells of the body. Pregnant women require sufficient amounts of iron for baby nourishment and oxygen supply. 70 percent of the iron in the body is attached hemoglobin. Lower levels of hemoglobin indicate anemia. Anemia problem can be treated with iron supplements or diet modifications. Hemochromatosis is a disease-causing absorption of too much iron from the diet. This disease causes irregular heartbeat, cancer and damage to the liver.

 

 

Site maps

Site map 1   Site map 2   Site map 3   Site map 4


The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.